Industry

AcuFocus Announces FDA Approval for the IC-8® Apthera™ Intraocular Lens, the First and Only Small Aperture Lens for Cataract Surgery

The Apthera extended depth of focus IOL uses proprietary small aperture technology to filter out peripheral defocused light, allowing only focused light to reach the retina. Results from the U.S. pivotal trial showed Apthera IOL subjects achieved statistically superior uncorrected intermediate and near vision, and equivalent distance vision and contrast sensitivity compared to control subjects. … [Read more…]

Global Peptide Therapeutics Market Insights & Forecasts 2022-2026 with Potential Impact of COVID-19 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Peptide Therapeutics Market (by Type, Synthesis Technology, Manufacturing Type, Application & Region): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)” report has been added to ResearchAndMarkets.com’s offering. The global peptide therapeutics market is expected to record a value of US$44.43 billion in 2026, progressing at a CAGR of 6.95%, over the … [Read more…]

Exclusive Report From Telosity: New Telosity report reveals 15X growth rate over the last four years in the U.S. mental health market

Extensive market guide, funded by Pivotal Ventures, unpacks the investment potential for investors and startups for tech-enabled solutions REDWOOD CITY, Calif.–(BUSINESS WIRE)–An exclusive report from Telosity by Vinaj Ventures reveals a record-breaking market demand for tech-enabled, mental health solutions to help combat rising rates of youth anxiety, depression and suicide. Providing extensive industry research and … [Read more…]

McKesson Raises Quarterly Dividend by 15% to $0.54 Per Share

IRVING, Texas–(BUSINESS WIRE)–The Board of Directors of McKesson Corporation (NYSE:MCK) declared on July 22, 2022 a regular dividend of $0.54 per share of common stock, a 15% increase from $0.47 per share in the prior quarter. The dividend will be payable on October 3, 2022, to stockholders of record on September 1, 2022. “This dividend … [Read more…]

Aviceda Therapeutics Announces Key Opinion Leader in Ophthalmology Drug Development Tarek S. Hassan, MD to Join Management Team as Chief Development Officer

 Tarek Hassan, MD: Past President of American Society of Retina Specialists and Retina World Congress; Clinical researcher: global randomized clinical trials (>150), peer-reviewed (230); founder 6 medical device and/or medical education companies; holder of numerous issued patents and inventions CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aviceda Therapeutics, Inc. a private biotechnology company located in Cambridge MA with a proprietary … [Read more…]

Eccovia Launches ClientInsight, an AI-Powered Data Warehouse to Improve Social Service Delivery

WASHINGTON–(BUSINESS WIRE)–Eccovia, a leading provider of cloud-based SaaS solutions for the health and human services sector, announces the release of an unprecedented data warehouse and community-analytics platform, ClientInsight. ClientInsight is hosted in Microsoft Azure and is a premier solution for data quality, performance, and actionable insights. Since the COVID-19 pandemic began, our nation’s most vulnerable … [Read more…]

Lifespin Significantly Expands its Proprietary Database of Human Health Profiles in Oncology Under Newly Established Cooperative Scientific Agreement with the Medical University of Graz

 Agreement will provide Lifespin with access to more than 25,000 longitudinal blood samples from approximately 4,800 oncological patients archived at Biobank Graz BOSTON–(BUSINESS WIRE)–Lifespin GmbH, based in Regensburg (Germany), with offices in Boston, Massachusetts, announced today that it has entered into a scientific collaborative agreement with Biobank Graz and the Clinical Division of Oncology of … [Read more…]

IAMA Therapeutics Announces Initiation of Preclinical Development Studies in Drug-resistant Epilepsy Under a Service Agreement with Psychogenics

GENOA, Italy–(BUSINESS WIRE)–#autism–IAMA Therapeutics, a preclinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel medicines to make a difference in the lives of individuals suffering from brain disorders, and PsychoGenics Inc., a leader in AI-enabled phenotypic drug discovery and preclinical CRO services, today announced that the companies have entered into a service … [Read more…]

Generate Biomedicines Bolsters Leadership Team With the Addition of Jason Silvers, M.D., J.D., as Chief Financial Officer

Former Goldman Sachs Co-head of EMEA Healthcare Investment Banking, Partner and Managing Director brings extensive experience in corporate biotech and strategic finance SOMERVILLE, Mass.–(BUSINESS WIRE)–Generate Biomedicines, whose machine learning-powered generative biology platform can rapidly invent new drugs across a wide range of protein modalities and previously undiscoverable protein therapeutics, today announced that Jason Silvers, M.D., … [Read more…]

DecisionDx®-Melanoma Ordered More Than 100,000 Times for Patients Diagnosed with Cutaneous Melanoma

Castle Biosciences surpasses 100,000 orders for its flagship risk-stratification test designed to help guide risk-appropriate treatment decisions for patients diagnosed with cutaneous melanoma FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #CSTL–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced a significant milestone for the Company’s DecisionDx®-Melanoma gene expression profile test, … [Read more…]